Preferred Label : decitabine and cedazuridine drug combination;
MeSH synonym : decitabine and cedazuridine; decitabine-cedazuridine; decitabine, cedazuridine; decitabine-cedazuridine drug combination;
Origin ID : C000723076;
UMLS CUI : C5390939;
MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.ema.europa.eu/en/medicines/human/EPAR/inaqovi
2024
false
false
false
Netherlands
French
English
decitabine and cedazuridine drug combination
decitabine and cedazuridine drug combination
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cedazuridine
cedazuridine
drug approval
europe
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
leukemia, myeloid, acute
administration, oral
risk management
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
decitabine, combinations
drug evaluation, preclinical
Product containing precisely cedazuridine 100 milligram and decitabine 35 milligram/1
each conventional release oral tablet (clinical drug)
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/inqovi-5667.html
2021
false
false
false
Canada
French
administration, oral
Product containing precisely cedazuridine 100 milligram and decitabine 35 milligram/1
each conventional release oral tablet (clinical drug)
drug evaluation
quebec
drug combinations
Decitabine
antimetabolites, antineoplastic
Decitabine and Cedazuridine
myelodysplastic syndromes
leukemia, myelomonocytic, chronic
decitabine and cedazuridine drug combination
decitabine, combinations
---
